Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Weihrauch (frankincense), specifically derived from the gum resin of the *Boswellia serrata* tree, is a traditional botanical extract widely used for its anti-inflammatory and joint-supporting properties. Marketed by MCM Klosterfrau under the brand name Gelenke Weihrauch, it is formulated as an oral dietary supplement to help maintain joint flexibility and support the overall health of the musculoskeletal system. The active components of Weihrauch, primarily boswellic acids, are believed to inhibit inflammatory pathways, such as the 5-lipoxygenase (5-LOX) enzyme, thereby reducing joint discomfort and stiffness associated with physical exertion, wear, or aging.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Weihrauch.